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1682-606X/Copyright ª 2015, TaiwanAbstract Acute intestinal ischemic disorders are potentially life threatening, making early
diagnosis and emergency surgery crucial. Although hypercoagulability may induce mesenteric
venous thrombosis, its association with mesenteric arterial thromboembolism remains contro-
versial. We present the case of a 52-year-old man with hypercoagulability-induced acute arte-
rial occlusive mesenteric ischemia. The patient suffered from arterial occlusive mesenteric
ischemia, recent ischemic stroke, and previous renal infarction. He had no history of atrial
fibrillation, atherosclerosis, vascular diseases, autoimmune diseases, malignancy, liver dis-
eases, copper deficiency, or other risk factors for arterial thromboembolism. Segmental resec-
tion of the gangrenous bowel with primary end-to-end anastomosis was performed. A
pathological examination revealed multiple thrombi within the mesenteric arteries of the
infarcted bowel without apparent atherosclerosis of the vessels. The plasma level of factor VIII
was high even 64 months postoperatively, which may have contributed to the recurrent and
multiple arterial thromboses. A lifelong oral anticoagulation therapy was suggested. From our
experience, we recommend that thrombophilia screening be performed in patients with acute
intestinal ischemic disorders, particularly in those with a history of recurrent or multiple throm-
boembolism. Anticoagulant therapy should be prescribed for those with hypercoagulability.
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Acute intestinal ischemic disorder (AIID), an uncommon but
potentially lethal disorder, can be categorized into arterial
occlusive mesenteric ischemia (AOMI), mesenteric venous
thrombosis (MVT), and nonocclusive mesenteric ischemia
(NOMI).1 AOMI is caused by mesenteric arterial thromboem-
bolism and is associated with cardiovascular diseases,
atherosclerosis, atrial fibrillation, and cardiogenic emboli.1
Although the hypercoagulable state commonly contributes
to MVT, hypercoagulability-induced AOMI is rare, and the
association between AOMI and the hypercoagulable state
remains controversial.2 Here, we present a case of sequen-
tial arterial ischemic events involving the kidney, brain, and
gastrointestinal tract over several years. Hypercoagulability
is associated with a high plasma level of factor VIII and may
have caused recurrent and multiple arterial thromboses in
this patient.
2. Case Report
A 52-year-old man was transferred to our emergency
department because of an acute onset of progressive
abdominal pain with an asymmetric facial expression, slow
response, incoherent speech, and cognitive impairment
within 2 days. He had a history of right renal arterial
infarction caused by thrombosis and had presented with
right flank pain and fever 3 years previously. The patient
did not smoke or experience chronic abdominal discomfort
before this episode and did not have any other comorbid-
ities or such risk factors for arterial thromboembolism as
hypertension, diabetes mellitus, dyslipidemia, cardiac
arrhythmia, valvular heart disease, atherosclerosis, auto-
immune disease, malignancy, liver disease, and copper
deficiency. In the emergency department, the patient was
acutely ill with intractable abdominal pain and his initial
body temperature was 37.8C with relatively stable vital
signs. Physical examination revealed marked rebound
tenderness in the left upper abdominal quadrant. Neuro-
logical examination revealed poor attention, impaired
short-term memory, shallow right nasolabial fold, and
mildly decreased muscle strength in the right lower
extremity.
Noncontrast computed tomography of the brain revealed
recent infarction of the left basal ganglia (Figure 1A).
Laboratory data showed prominent leukocytosis with a left
shift (white blood cell count 21.0  103/mm3, normal
3.2e9.2  103/mm3; bands neutrophils 7%, normal 0%;
segmented neutrophils 82.5%, normal 43e64%) and an
elevated level of plasma C-reactive protein (CRP; 88.6 mg/
L, normal < 8 mg/L). Furthermore, contrast-enhanced
abdominal computed tomography revealed partial defects
within the superior mesenteric artery (Figure 1B), focal
dilatation of the jejunum with wall thickening, poor
enhancement and pneumatosis intestinalis (Figure 1C),
adjacent fat stranding, and focal ascites (Figure 1D).
Emergency exploratory laparotomy was performed for
treating acute intestinal ischemia. An approximately 120-
cm long gangrenous segment of the jejunum was observed
and segmental resection of the bowel with primary end-to-
end anastomosis was performed. The residual bowel and allother intraabdominal viscera were carefully inspected
intraoperatively; no abnormalities were noted. Intra-
operative transesophageal echocardiography did not reveal
cardiac arrhythmia, intracardiac thrombosis, vegetation, or
aortic atheroma.
Pathological examination showed multiple thrombi
within the mesenteric arteries of the infarcted bowel but
no apparent atherosclerosis of the vessels. Heparin was
administered in the immediate postoperative period with a
gradual transition to warfarin. A coagulation screen
revealed a thrombophilia with an increased activity of
plasma factor VIII and borderline deficiency of protein C
(Figure 2). Plasma activities of factor V and antithrombin III
were within the normal ranges (factor V 75%, normal
50e150%; antithrombin III 92%, normal 58e118%; Table 1).
Tests conducted for antiphospholipid antibodies (anti-car-
diolipin antibody, immunoglobulins M and G), autoimmune
diseasesdincluding systemic lupus erythematosus and
rheumatoid arthritis (rheumatoid factor < 20 IU,
normal < 20 IU)doccult malignancy, and copper deficiency
were negative.
The patient was discharged 2 weeks postoperatively and
could independently perform daily activities with only mild
neurological sequelae thereafter. He exhibited recurrent
and multiple arterial thromboses without evidence of
cardiogenic thromboembolism or systemic atherosclerosis;
therefore, hypercoagulability was suspected. The plasma
factor VIII level was consistently high with a borderline low
activity of protein C at 64 months postoperatively (Figure 2).
A lifelong anticoagulant therapy instead of antiplatelet
therapy alone was suggested to this patient for
hypercoagulability-induced recurrent and multiple arterial
thromboses. The patient is presently healthy and regularly
receives warfarin prophylaxis.3. Discussion
Despite advances in diagnostic and therapeutic modalities,
the morbidity and mortality rates of AIID have remained
high and without considerable improvement for several
years.1,3 Prompt detection and adequate management of
AIID remain challenging for physicians. AIID is categorized
into AOMI, MVT, and NOMI according to their underlying
etiologies and prognostic outcomes.1 AOMI can be caused
by either mesenteric arterial embolism or thrombosis,
although arterial embolism is more common.1 Similar to
other embolic events, mesenteric arterial embolism mostly
arises from a cardiac source, such as cardiac arrhythmia,
valvular disease, congestive heart failure, and recent
myocardial infarction.3 Multiple synchronous emboli
affecting other visceral arteries are often observed in pa-
tients with cardiac arrhythmia.3 Furthermore, mesenteric
arterial thrombosis generally results from atherosclerosis of
the mesenteric vessels and the associated risk factors
include smoking, hypertension, diabetes mellitus, dyslipi-
demia, and other atherosclerotic diseases.1,3 Patients with
AOMI always have some predisposing factors.
MVT is the least common and has the most favorable
outcome amongst the three AIID categories.1 Resembling
other venous thrombotic diseases, the most common MVT
etiologies include venous stasis and heritable or acquired
Figure 1 Computed tomography of the brain and abdomen. (A) One hypodense lesion is evident at the basal ganglia of the left
hemisphere (arrow) in a noncontrast computed tomography of the brain. (BeD) Contrast-enhanced computed tomography of the
abdomen. (B) One filling defect (arrow) is detected in the root of the superior mesenteric artery in transverse and (C) sagittal
scans. (D) Dilatation of the jejunum with thick and poorly enhanced wall (arrowheads) and pneumatosis intestinalis (arrow) is
evident in the atrophied right kidney because of previous renal infarction.
Figure 2 Plasma level of factor VIII and protein C activity. (A) The plasma factor VIII level is elevated 64 months after thrombosis.
(B) Borderline decreased protein C activity is simultaneously detected. Post-OP Z post-operation.
Table 1 Plasma activity of coagulation factors.
Reference range Postoperative time (mo)
0 0.3 1 3 12 14 27 43 64
Protein C (%) 67e167 25.4 d d d d 56.4 41.5 50.4 32.8
Protein S (%) 60e140 168.9 d d d d 33 28.1 85.6 74.4
Factor VIII (%) 58e118 214 206.3 193.5 178.2 118.4 168.2 158.2 174.3 185.2
Factor V (%) 50e150 75.23 d d d d 128.2 d d d
Antithrombin III (%) 78e151 91.94 d d d d 129 d d d
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bophilia, malignancies, intraabdominal infections, major
operations, portal hypertension, or idiopathy.1,2 Activated
protein C resistance, protein C or S deficiency, lupus anti-
coagulant, and factor V Leiden and prothrombin G20210A
mutations have been reportedly associated with MVT.2,4
Otherwise, hypercoagulability is not associated with most
AOMI cases. Hypercoagulability-related AOMI is reported
only in one case report, highlighting its rare occurrence.5
Thrombophilia screening is recommended for patients
with unexplained, recurrent, or unusually located venous
thromboembolism (VTE) and for young patients with VTE
(less than 50 years).6 Antithrombin III, proteins C and S,
factor V and prothrombin mutations, lupus anticoagulant,
antiphospholipid antibodies, and occult malignancy should
be screened.2,6 Routine screening for thrombophilic con-
ditions is not recommended in most cases of arterial
thromboembolism; however, recent studies have reported
that venous and arterial thromboses may share some risk
factors, such as age, metabolic syndromes, and inflamma-
tory conditions.6e8 The coagulation process or platelet
activation is critical in the development of both venous and
arterial thrombosis.7 Thus, appropriate screening for hy-
percoagulability benefits patients with recurrent and mul-
tiple arterial thromboses and those without typical risk
factors for arterial thromboembolism.
During thrombin and fibrin production, factor VIII is
activated and forms a complex with activated factor IX.
Factor VIII and von Willebrand factor circulate in the plasma
as a complex, and a deficiency of these factors cause the
inherited bleeding disorders, hemophilia A and von Wille-
brand disease, respectively.7 An elevated plasma level of
factor VIII is positively associated with VTE.8 Although
inconsistent, some studies have shown that factor VIII
elevation is an independent risk factor for coronary artery
disease and ischemic stroke.9 Although the reason for factor
VIII hyperactivity remains unclear, hereditary factor VIII
elevation is strongly believed to be a potential cause.8,9 To
our knowledge, this is the first report in English reporting
AOMI associated with an elevated level of factor VIII.
Except for DNA testing for factor V Leiden and pro-
thrombin G20210A mutations, thrombophilia screening test
results can be altered during an acute thrombotic phase,
inflammatory state, or with anticoagulant therapy.6 The
thrombophilia test requires a detailed explanation for pa-
tients receiving anticoagulant treatment because warfarin
inhibits the vitamin K-dependent synthesis of clotting fac-
tors. A long-term warfarin usage suppresses protein C syn-
thesis.10 Furthermore, warfarin reduced the plasma level of
protein C in our patient to slightly below the normal range
(Figure 2B). Although unaffected by anticoagulants, factor
VIII is an acute-phase reactant and thus a later measure-
ment is necessary for confirming the activity of factor VIII.The plasma factor VIII level in our patient was high at
64 months postoperatively, confirming the intrinsic hyper-
activity of factor VIII. Therefore, a lifelong anticoagulant
therapy is indicated to prevent the recurrence of arterial
thrombosis.
Although uncommon, hypercoagulability can cause
AOMI, particularly in patients without known risk factors for
arterial thromboembolism. An initial thrombophilia
screening is frequently inconclusive; therefore, repeated
examination is required and lifelong anticoagulant should
be considered for patients with recurrent and multiple
arterial thrombotic events caused by hypercoagulability.Acknowledgments
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